enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 8-K
Filing Date: 10 Jun 2026Report Date: 09 Jun 2026
Accepted: 10 Jun 2026 02:09 p.m.
Accession Number: 0001193125-26-265830
File Number: 001-41854
Film Number: 261079743
Items: 5.07,9.01
Documents
Primary Document: 8-K
Accepted: 10 Jun 2026 02:09 p.m.
0001193125-26-265830-index-headers.html
Last Modified: 10 Jun 2026 02:09 p.m.
0001193125-26-265830-index.html
Last Modified: 10 Jun 2026 02:09 p.m.
0001193125-26-265830.txt
Last Modified: 10 Jun 2026 02:09 p.m.
0001193125-26-265830-xbrl.zip
Last Modified: 10 Jun 2026 02:09 p.m.
engn-20260609.xsd
Last Modified: 10 Jun 2026 02:09 p.m.
engn-20260609_htm.xml
Last Modified: 10 Jun 2026 02:09 p.m.
FilingSummary.xml
Last Modified: 10 Jun 2026 02:09 p.m.
MetaLinks.json
Last Modified: 10 Jun 2026 02:09 p.m.
R1.htm
Last Modified: 10 Jun 2026 02:09 p.m.
report.css
Last Modified: 10 Jun 2026 02:09 p.m.
Show.js
Last Modified: 10 Jun 2026 02:09 p.m.